Hybrid capture 2 viral load and the 2-year cumulative risk of cervical intraepithelial neoplasia grade 3 or cancer
- 30 November 2004
- journal article
- research article
- Published by Elsevier BV in American Journal of Obstetrics and Gynecology
- Vol. 191 (5), 1590-1597
- https://doi.org/10.1016/j.ajog.2004.05.018
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Management of women who test positive for high-risk types of human papillomavirus: the HART studyThe Lancet, 2003
- Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significanceAmerican Journal of Obstetrics and Gynecology, 2003
- Adding a Test for Human Papillomavirus DNA to Cervical-Cancer ScreeningNew England Journal of Medicine, 2003
- Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical CancerNew England Journal of Medicine, 2003
- Baseline Cytology, Human Papillomavirus Testing, and Risk for Cervical Neoplasia: A 10-Year Cohort AnalysisJNCI Journal of the National Cancer Institute, 2003
- American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and CancerCA: A Cancer Journal for Clinicians, 2002
- Comparison of Three Management Strategies for Patients With Atypical Squamous Cells of Undetermined Significance: Baseline Results From a Randomized TrialJNCI Journal of the National Cancer Institute, 2001
- Human papillomavirus is a necessary cause of invasive cervical cancer worldwideThe Journal of Pathology, 1999
- Identifying Women With Cervical NeoplasiaPublished by American Medical Association (AMA) ,1999
- Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide PerspectiveJNCI Journal of the National Cancer Institute, 1995